论文部分内容阅读
目的:分析研究吗啡缓释片治疗晚期癌症疼痛的临床疗效及不良反应。方法:选取2014年1月-2016年1月在我院接收的晚期癌症患者一共有82例,随机分为实验组、对照组,对照组对患者采取泰勒宁进行治疗,实验组对患者采取吗啡缓释片进行治疗,对两组患者的治疗效果和不良反应给予对比。结果:治疗以后,实验组患者的总有效率高于对照组(P<0.05);治疗以后,实验组患者的不良反应低于对照组(P<0.05)。结论:对晚期癌症患者采取吗啡缓释片进行治疗,可以使患者疼痛明显减轻,同时不良反应较低,具有安全有效性。
Objective: To analyze the clinical efficacy and adverse reactions of morphine sustained-release tablets in the treatment of advanced cancer pain. METHODS: A total of 82 patients with advanced cancer who were admitted to our hospital from January 2014 to January 2016 were randomly divided into experimental group, control group and control group. The patients were treated with tylosin, and the experimental group took morphine Sustained release tablets for treatment, the two groups of patients treated with adverse reactions and given contrast. Results: After the treatment, the total effective rate of the experimental group was higher than that of the control group (P <0.05). After the treatment, the adverse reactions in the experimental group were lower than those in the control group (P <0.05). Conclusion: It is safe and effective to take morphine sustained-release tablets for patients with advanced cancer to relieve the pain significantly and at the same time lower adverse reactions.